These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12544257)

  • 1. Resistance to chemotherapeutic drugs overcome by c-Myc inhibition in a Lewis lung carcinoma murine model.
    Knapp DC; Mata JE; Reddy MT; Devi GR; Iversen PL
    Anticancer Drugs; 2003 Jan; 14(1):39-47. PubMed ID: 12544257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-MYC antisense phosphosphorodiamidate morpholino oligomer inhibits lung metastasis in a murine tumor model.
    Sekhon HS; London CA; Sekhon M; Iversen PL; Devi GR
    Lung Cancer; 2008 Jun; 60(3):347-54. PubMed ID: 18096271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.
    Devi GR; Oldenkamp JR; London CA; Iversen PL
    Prostate; 2002 Nov; 53(3):200-10. PubMed ID: 12386920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans.
    Iversen PL; Arora V; Acker AJ; Mason DH; Devi GR
    Clin Cancer Res; 2003 Jul; 9(7):2510-9. PubMed ID: 12855625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide.
    Mizutani Y; Fukumoto M; Bonavida B; Yoshida O
    Cancer; 1994 Nov; 74(9):2546-54. PubMed ID: 7923012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability and efficacy of antisense morpholino oligomers targeted to c-myc and cytochrome P-450 3A2 following oral administration in rats.
    Arora V; Knapp DC; Reddy MT; Weller DD; Iversen PL
    J Pharm Sci; 2002 Apr; 91(4):1009-18. PubMed ID: 11948540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acridine-modified, clamp-forming antisense oligonucleotides synergize with cisplatin to inhibit c-Myc expression and B16-F0 tumor progression.
    Stewart DA; Xu X; Thomas SD; Miller DM
    Nucleic Acids Res; 2002 Jun; 30(11):2565-74. PubMed ID: 12034846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC1 Silencing in Ovarian Cancer Enhances the Chemotherapy Response.
    Liu X; Yu Y; Zhang J; Lu C; Wang L; Liu P; Song H
    Cell Physiol Biochem; 2018; 48(4):1505-1518. PubMed ID: 30071534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents.
    Klingbeil O; Lesche R; Gelato KA; Haendler B; Lejeune P
    Cell Death Dis; 2016 Sep; 7(9):e2365. PubMed ID: 27607580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.
    Xie XK; Yang DS; Ye ZM; Tao HM
    Chemotherapy; 2009; 55(6):433-40. PubMed ID: 19996588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Myc antisense limits rat liver regeneration and indicates role for c-Myc in regulating cytochrome P-450 3A activity.
    Arora V; Knapp DC; Smith BL; Statdfield ML; Stein DA; Reddy MT; Weller DD; Iversen PL
    J Pharmacol Exp Ther; 2000 Mar; 292(3):921-8. PubMed ID: 10688605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiproliferative effects of steric blocking phosphorodiamidate morpholino antisense agents directed against c-myc.
    Hudziak RM; Summerton J; Weller DD; Iversen PL
    Antisense Nucleic Acid Drug Dev; 2000 Jun; 10(3):163-76. PubMed ID: 10905553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers.
    Geller BL; Deere JD; Stein DA; Kroeker AD; Moulton HM; Iversen PL
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3233-9. PubMed ID: 14506035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Qiyusanlong decoction inhibits the level of PD-1/PD-L1 in mice bearing Lewis lung carcinoma].
    Zhang X; Tong J; Li Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):770-4. PubMed ID: 27371844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-myc antisense oligonucleotides sensitize human colorectal cancer cells to chemotherapeutic drugs.
    Abaza MS; Al-Saffar A; Al-Sawan S; Al-Attiyah R
    Tumour Biol; 2008; 29(5):287-303. PubMed ID: 18802399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
    Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo bioavailability and pharmacokinetics of a c-MYC antisense phosphorodiamidate morpholino oligomer, AVI-4126, in solid tumors.
    Devi GR; Beer TM; Corless CL; Arora V; Weller DL; Iversen PL
    Clin Cancer Res; 2005 May; 11(10):3930-8. PubMed ID: 15897595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
    Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
    Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
    J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a phosphorodiamidate morpholino oligomer antisense compound in the inhibition of corneal transplant rejection in a rat cornea transplant model.
    Hosseini A; Lattanzio FA; Samudre SS; DiSandro G; Sheppard JD; Williams PB
    J Ocul Pharmacol Ther; 2012 Apr; 28(2):194-201. PubMed ID: 22149555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.